Nasus Pharma Ltd. (NSRX) - Latest Market Data

Price & Market Data

Price: $2.90

Daily Change: +$0.03 / 1.03%

Daily Range: $2.81 - $2.96

Market Cap: $33,961,348

Daily Volume: 9,540

Performance Metrics

1 Week: 0.44%

1 Month: -16.78%

3 Months: -41.75%

6 Months: -61.16%

1 Year: -63.59%

YTD: -68.51%

About Nasus Pharma Ltd. (NSRX)

Your comprehensive guide to Nasus Pharma Ltd. (NSRX). Price: 2.90, daily change: +$0.03 / 1.03%. Market cap: 33,961,348. Full range of performance data for investors.

Company Details

Employees: 7

Sector: Health technology

Industry: Pharmaceuticals: major

Country: Israel

Details

Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.

Selected stocks

Black Titan Corp (BTTC)

Brasilagro Brazilian Agric Real Estate Co Sponsored (LND)

Morgan Stanley Emerging Markets Domestic Debt Fund, Inc. (EDD)

OMS Energy Technologies Inc. (OMSE)